Ignite Creation Date:
2025-12-18 @ 9:58 AM
Ignite Modification Date:
2025-12-23 @ 6:58 PM
Study NCT ID:
NCT04040322
Status:
None
Last Update Posted:
2025-05-25 00:00:00
First Post:
2019-07-30 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3)
Sponsor:
None
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10-14
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-09
Completion Date Type:
ACTUAL
First Submit Date:
2019-07-30 00:00:00
First Submit QC Date:
None
Study First Post Date:
2019-07-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-04-23 00:00:00
Results First Submit QC Date:
None
Results First Post Date:
2025-05-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-09 00:00:00
Last Update Post Date:
2025-05-25 00:00:00
Last Update Post Date Type:
ACTUAL